36E79721D0042
Indefinite Delivery Contract
Overview
Government Description
NEW AWARD FOR THIORIDAZINE HCL TABLETS WITH MYLAN. PERIOD OF PERFORMANCE IS AUG 19, 2021 TO AUG 18, 2022 WITH FOUR ONE-YEAR OPTIONS.
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$267,666 (0% Used)
Related Opportunity
Analysis Notes
Amendment Since initial award the Ordering Period End Date was extended from 08/18/22 to 08/18/25.
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Mylan Pharmaceuticals was awarded
Indefinite Delivery Contract 36E79721D0042 (36E797-21-D-0042)
by
National Acquisition Center
for New Award For Thioridazine Hcl Tablets With Mylan. Period Of Performance Is Aug 19, 2021 To Aug 18, 2022 With Four One-Year Options.
in August 2021.
The IDC
has a duration of 4 years and
was awarded
through solicitation Thioridazine Tablets
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 1 bid received.
The total ceiling is $267,666, of which 0% has been used.
Status
(Open)
Modified 6/25/24
Period of Performance
8/18/21
Start Date
8/18/25
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36E79721D0042
Transaction History
Modifications to 36E79721D0042
People
Suggested agency contacts for 36E79721D0042
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
NDN1MYB8DKK5
Awardee CAGE
3KJG9
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
matthew.poulin@va.gov
Last Modified By
nicholas.mcgregor@va.gov
Approved By
nicholas.mcgregor@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
WV-02
Senators
Joe Manchin
Shelley Capito
Shelley Capito
Representative
Alexander Mooney
Last Modified: 6/25/24